Cell viability assay protocol for evaluating the biocompatibility of nanomaterials using the MTT colorimetric method.
Biological Protocol
This protocol describes the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay for assessing nanoparticle cytotoxicity in cultured cells. The method quantifies cell viability based on mitochondrial metabolic activity and provides IC₅₀ values for nanoparticle formulations. The protocol includes cell seeding, nanoparticle treatment, MTT incubation, and colorimetric measurement.
No case studies have been documented for this protocol yet.
Login to Add Case StudyRequest automation of this protocol using NanoScience Lab equipment. Our team will review the protocol, provide a quote, and perform the automation using state-of-the-art nanotechnology hardware.
Medic Tech. (2026). MTT Assay for Nanoparticle Cytotoxicity Assessment. Protocol ID: proto-261-o48v. Retrieved from https://protoly.net/proto-261-o48v
Medic Tech. "MTT Assay for Nanoparticle Cytotoxicity Assessment." Protocol ID proto-261-o48v, 2026. Web. 09 Mar 2026.
Medic Tech. "MTT Assay for Nanoparticle Cytotoxicity Assessment." Protocol ID: proto-261-o48v. Accessed March 09, 2026. https://protoly.net/proto-261-o48v.